[Federal Register: January 20, 2010 (Volume 75, Number 12)]
[Notices]
[Page 3224-3225]
[DOCID:fr20ja10-63]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. PF09-15-000]

Dominion Transmission, Inc.; Notice of Public Scoping Meetings
for the Appalachian Gateway Project

January 8, 2010.
    The staff of the Federal Energy Regulatory Commission (FERC or
Commission) will prepare an environmental assessment (EA) that will
discuss the environmental impacts of the Appalachian Gateway Project
involving construction and operation of facilities by Dominion
Transmission, Inc. (DTI) in northeastern West Virginia (WV) and
southwestern Pennsylvania (PA). The EA will be used by the Commission
in its decision-making process to determine whether the project is in
the public convenience and necessity.
    This notice announces the dates and locations of the scoping
meetings FERC staff will be holding to gather input from the public and
interested agencies on the project. Your input will help the Commission
staff determine what issues need to be evaluated in the EA. You are
invited to attend the public scoping meetings that have been scheduled
as follows:
    Wednesday, January 20, 2010 at 6 p.m. (EST), Youghiogheny Ballroom,
100 Riverside Drive, West Newton, PA.
    Thursday, January 21, 2010 at 6 p.m.(EST), Waynesburg Central High
School--Auditorium, 30 Zimmerman Drive, Waynesburg, PA.
    Wednesday, January 27, 2010 at 6 p.m. (EST), Valley High School--
Auditorium, One Lumberjack Lane, Pine Grove, WV.
    Thursday, January 28, 2010 at 6 PM (EST), Riverside High School--
Auditorium, 1 Warrier Way, Belle, WV.
    This notice is being sent to the Commission's current environmental
mailing for this project, which includes affected landowners; federal,
state, and local government representatives and agencies; elected
officials; environmental and public interest groups; Native American
Tribes; other interested parties; and local libraries and newspapers.
State and local government representatives are asked to notify their
constituents of this planned project and encourage them to comment on
their areas of concern.

Summary of the Planned Project

    DTI plans to construct and operate approximately 110 miles of 20-,
24-, and 30-inch diameter natural gas pipeline and associated
aboveground facilities in northeastern West Virginia and southwestern
Pennsylvania. According to DTI, its project would provide about 484,260
dekatherms of natural gas per day of firm transportation services from
increasing gas production in the Appalachian region of West Virginia
and Pennsylvania to the east coast markets.
    The Appalachian Gateway Project would consist of the following
facilities:
     Approximately 43.1 miles of 30-inch diameter pipeline in
Marshall County, WV and Greene County, PA;
     Approximately 54.2 miles of 24-inch diameter pipeline in
Greene, Washington, Allegheny, and Westmoreland Counties, PA;
     Approximately 5.2 miles of 20-inch diameter pipeline loop
in Kanawha County, WV and 6 miles of 24-inch diameter pipeline loop in
Greene County, PA; \1\
---------------------------------------------------------------------------

    \1\ A pipeline loop is constructed parallel to an existing
pipeline to increase capacity.
---------------------------------------------------------------------------

     A total of approximately 1.5 miles of various diameter
discharge and suction pipelines to serve the Lewis-Wetzel Compressor
Station (Wetzel County, WV) and the Morrison Compressor Station
(Harrison County, WV);
     Two new compressor stations on new sites: Burch Ridge
Station

(Marshall County, WV) with approximately 6,130 horsepower (HP) and
Morrison Station (Harrison County, WV) with approximately 1,775 HP;
     Two new compressor stations on existing sites: Chelyan
Station (Kanawha County, WV) with approximately 4,735 HP and Lewis
Wetzel Station (Wetzel County, WV) with approximately 3,550 HP;
     A new metering and regulation facility at the existing
Oakford Compressor Station in Westmoreland County, PA; and
     Upgrades and minor additions to other existing facilities
in Wyoming, Doddridge, McDowell, and Barbour Counties, WV.

Additional Information

    Additional information about the project is available from the
Commission's Office of External Affairs, at 1-866-208-FERC or on the
FERC Web site (http://www.ferc.gov) using the eLibrary link. Click on
the eLibrary link, click on ``General Search'' and enter the docket
number, excluding the last three digits, in the Docket Number field
(PF09-15). Be sure you have selected an appropriate date range. For
assistance, please contact FERC Online Support at
<EMAIL_ADDRESS>or toll free at 1-866-208-3676, or for TTY,
contact<PHONE_NUMBER>. The eLibrary link also provides access to the
texts of formal documents issued by the Commission, such as orders,
notices, and rulemakings.
    In addition, the Commission offers a free service called
eSubscription which allows you to keep track of all formal issuances
and submittals in specific dockets. This can reduce the amount of time
you spend researching proceedings by automatically providing you with
notification of these filings, document summaries and direct links to
the documents. Go to http://www.ferc.gov/esubscribenow.htm.
    Finally, any additional public meetings or site visits will be
posted on the Commission's calendar located at http://www.ferc.gov/
EventCalendar/EventsList.aspx along with other related information.

Kimberly D. Bose,
Secretary.
[FR Doc. 2010-916 Filed 1-19-10; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register: April 30, 2010 (Volume 75, Number 83)]
[Notices]
[Page 22813-22814]
[DOCID:fr30ap10-92]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2008-D-0263]

Guidance for Industry: Requalification Method for Reentry of
Blood Donors Deferred Because of Reactive Test Results for Antibody to
Hepatitis B Core Antigen (Anti-HBc); Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of a document entitled ``Guidance for Industry:
Requalification Method for Reentry of Blood Donors Deferred Because of
Reactive Test Results for Antibody to Hepatitis B Core Antigen (Anti-
HBc),'' dated May 2010. The guidance document provides recommendations
to establishments that collect Whole Blood or blood components intended
for transfusion, with recommendations for a requalification method or
process for reentering deferred donors into the donor pool based on a
determination that previous tests that were repeatedly reactive for
antibodies to hepatitis B core antigen (anti-HBc) were falsely positive
and that there is no evidence of infection with hepatitis B virus
(HBV). These recommendations are based on the recent availability of
FDA-licensed hepatitis B virus nucleic acid tests (HBV NAT) that are
particularly sensitive when single samples are tested. These tests
provide an additional, powerful method of determining whether a donor
who has been deferred because of anti-HBc reactivity is truly infected
by HBV. The guidance announced in this notice finalizes the draft
guidance of the same title dated May 2008.

DATES: Submit written or electronic comments on agency guidances at any
time.

ADDRESSES: Submit written requests for single copies of the guidance to
the Office of Communication, Outreach and Development (HFM-40), Center
for Biologics Evaluation and Research (CBER), Food and Drug
Administration, 1401 Rockville Pike, suite 200N, Rockville, MD 20852-
1448. Send one self-addressed adhesive label to assist the office in
processing your requests. The guidance may also be obtained by mail by
calling CBER at 1-800-835-4709 or<PHONE_NUMBER>. See the SUPPLEMENTARY
INFORMATION section for electronic access to the guidance document.
    Submit written comments on the guidance to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
rm. 1061, Rockville, MD 20852. Submit electronic comments to http://
www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Paul E. Levine, Jr., Center for
Biologics Evaluation and Research (HFM-17), Food and Drug
Administration, 1401 Rockville Pike, suite 200N, Rockville, MD 20852-
1448,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    FDA is announcing the availability of a document entitled
``Guidance for Industry: Requalification Method for Reentry of Blood
Donors Deferred Because of Reactive Test Results for Antibody to
Hepatitis B Core Antigen (Anti-HBc),'' dated May 2010. The guidance
document provides recommendations to establishments that collect Whole
Blood or blood components for a requalification method or process for
the reentry of deferred donors into the donor pool based on a
determination that previous tests that were repeatedly reactive for
anti-HBc were falsely positive and that there is no evidence of
infection with HBV. Currently, donors who are repeatedly reactive on
more than one occasion for anti-HBc (samples from more than one
collection from the donor are repeatedly reactive for anti-HBc) must be
indefinitely deferred in accordance with current regulations.
Situations have occurred with some frequency in which two anti-HBc
tests are false positives because of the relative non-specificity of
these tests. The result is that many otherwise suitable donors are
indefinitely deferred because of their anti-HBc test results even
though medical follow-up of such donors indicates that they are not
infected with HBV. FDA-licensed HBV NAT assays, which are particularly
sensitive when single samples are tested, are now available and provide
an additional, powerful method of determining whether a donor who has
been deferred because of anti-HBc reactivity is truly infected by HBV.
Due to the availability of FDA-licensed HBV NAT assays and the improved
specificity of anti-HBc assays, FDA is recommending in the guidance a
reentry algorithm for donors deferred due to falsely positive
repeatedly reactive tests for anti-HBc.
    In the Federal Register of May 21, 2008 (73 FR 29519), FDA
announced the availability of the draft guidance of the same title. FDA
received several comments on the draft guidance and those comments were
considered as the guidance was finalized. In addition, editorial
changes were made to improve clarity. The guidance announced in this
notice finalizes the draft guidance dated May 2008.
    The guidance is being issued consistent with FDA's good guidance
practices regulation (21 CFR 10.115). The guidance represents FDA's
current thinking on this topic. It does not create or confer any rights
for or on any person and does not operate to bind FDA or the public. An
alternative approach may be used if such approach satisfies the
requirements of the applicable statutes and regulations.

II. Paperwork Reduction Act of 1995

    This guidance refers to previously approved collections of
information found in FDA regulations. These collections of information
are subject to review by the Office of Management and Budget (OMB)
under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The
collections of information in 21 CFR 601.12 have been approved under
OMB control number 0910-0338.

III. Comments

    Interested persons may, at any time, submit to the Division of
Dockets Management (see ADDRESSES) written or electronic comments
regarding the guidance. Submit a single copy of electronic comments or
two paper copies of any mailed comments, except that individuals may
submit one paper copy. Comments are to be identified

with the docket number found in brackets in the heading of this
document. A copy of the guidance and received comments are available
for public examination in the Division of Dockets Management between 9
a.m. and 4 p.m., Monday through Friday.

IV. Electronic Access

    Persons with access to the Internet may obtain the guidance at
either: http://www.fda.gov/BiologicsBloodVaccines/
GuidanceComplianceRegulatoryInformation/Guidances/default.htm, http://
www.fda.gov/cber/guidelines.htm or http://www.regulations.gov.

    Dated: April 16, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-10046 Filed 4-29-10; 8:45 am]
BILLING CODE 4160-01-S


[Federal Register: June 25, 2007 (Volume 72, Number 121)]
[Notices]
[Page 34672-34673]
[DOCID:fr25jn07-48]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP07-396-000]

 Gulf South Pipeline Company, LP; Notice of Request Under Blanket
Authorization

June 18, 2007.
    Take notice that on June 8, 2007, Gulf South Pipeline Company, LP
(Gulf South), 9 Greenway Plaza, Suite 2800, Houston, Texas 77046, filed
in Docket No. CP07-396-000, a prior notice request pursuant to sections
157.205 and 157.208 of the Federal Energy Regulatory Commission's
regulations under the Natural Gas Act for authorization to construct,
own, and operate two new compressor stations on its existing natural
gas transmission pipeline facilities in Mobile County, Alabama, all as
more fully set forth in the application, which is on file with the
Commission and open to public inspection. The filing may also be viewed
on the web at http://www.ferc.gov using the ``eLibrary'' link. Enter

the docket number excluding the last three digits in the docket number
field to access the document. For assistance, contact FERC at
<EMAIL_ADDRESS>or call toll-free,<PHONE_NUMBER> or TYY,

(202) 502-8659.

    Specifically, Gulf South proposes to construct, own, operate, and
maintain two new compressor stations, the Whistler Junction Compressor
Station (Whistler Junction) and the Airport Junction Compressor Station
(Airport Junction) in Mobile County, Alabama, to satisfy the growing
demand for natural gas in the Southeastern United States. These
compressor stations are designed to deliver, on a firm basis, 250,000
Dth per day to Gulfstream Natural Gas System, L.L.C. (Gulfstream), an
interstate pipeline, at an existing interconnect near Coden, Alabama in
Mobile County. Whistler Junction will consist of one 4,680 horsepower
Solar Centaur 40-4700S turbine engine equipped with Solar's
``SoLoNOX'' system. Airport Junction will consist of one
4,735 horsepower Caterpillar G3616 TALE reciprocating engine equipped
with a low-NOX burner system. A new office and controls
building will also be constructed. No wetlands are impacted by the
project. All construction will be contained within Gulf South's
property. Gulf South will finance the facilities with funds on hand.
The estimated cost of the facilities is $22,985,103.
    Any questions regarding the application should be directed to J.
Kyle Stephens, Vice President, Regulatory Affairs, Gulf South Pipeline
Company, LP, 20 East Greenway Plaza, Suite 1000, Houston Texas 77046,
or call at<PHONE_NUMBER>.
    Any person or the Commission's Staff may, within 60 days after the
issuance of the instant notice by the Commission, file pursuant to Rule
214 of the Commission's Procedural Rules (18 CFR 385.214) a motion to
intervene or notice of intervention and, pursuant to section 157.205 of
the Commission's Regulations under the Natural Gas Act (NGA) (18 CFR
157.205) a protest to the request. If no protest is filed within the
time allowed therefore, the proposed activity shall be deemed to be
authorized effective the day after the time allowed for protest. If a
protest is filed and not withdrawn within 30 days after the time
allowed for filing a protest, the instant request shall be treated as
an application for authorization pursuant to Section 7 of the NGA.
    The Commission strongly encourages electronic filings of comments,
protests, and interventions via the internet in lieu of paper. See 18
CFR 385.2001(a)(1)(iii) and the instructions on the Commission's Web
site (http://www.ferc.gov) under the ``e-Filing'' link.

Kimberly D. Bose,
Secretary.
[FR Doc. E7-12182 Filed 6-22-07; 8:45 am]

BILLING CODE 6717-01-P